𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment

✍ Scribed by Ulrike Heider; Martin Kaiser; Maren Mieth; Britta Lamottke; Jessica Rademacher; Christian Jakob; Edgar Braendle; David Stover; Orhan Sezer

Book ID
114794493
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
224 KB
Volume
82
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Elevated serum concentration of hepatocy
Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: Correlation with markers of disease activity
✍ M.G. Alexandrakis; F.H. Passam; A. Sfiridaki; E. Kandidaki; P. Roussou; D.S. Kyr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in angiogenesis, epithelial cell proliferation, and osteoclast activation. HGF and its receptor are expressed on myeloma cell lines and could be involved in the pathogenesis of bone destruction in multiple myeloma (MM). The ai

Serum concentrations of Dickkopf-1 prote
Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation
✍ Marianna C. Politou; Deborah J. Heath; Amin Rahemtulla; Richard Szydlo; Athanasi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 101 KB πŸ‘ 1 views

## Abstract Dickkopf‐1 (DKK‐1) protein, a soluble inhibitor of Wnt signalling, has been implicated in the pathogenesis of myeloma bone disease through the suppression of osteoblast differentiation. In this study, serum concentrations of DKK‐1 were measured in 50 myeloma patients (32 at diagnosis an